These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8363220)

  • 1. Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.
    Schorlemmer HU; Dickneite G
    Ann N Y Acad Sci; 1993 Jun; 685():155-74. PubMed ID: 8363220
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases.
    Carlson RP; Baeder WL; Caccese RG; Warner LM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():86-113. PubMed ID: 8363289
    [No Abstract]   [Full Text] [Related]  

  • 3. 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
    Schorlemmer HU; Bartlett RR; Seiler FR
    Agents Actions; 1991 Sep; 34(1-2):151-5. PubMed ID: 1793021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
    Lange F; Bajtner E; Rintisch C; Nandakumar KS; Sack U; Holmdahl R
    Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases.
    Burkhardt H; Kalden JR
    Rheumatol Int; 1997; 17(3):85-90. PubMed ID: 9352601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulatory capacity of interleukin-21 in the pathogenesis of autoimmune disease.
    Vogelzang A; King C
    Front Biosci; 2008 May; 13():5304-15. PubMed ID: 18508588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.
    Nemoto K; Mae T; Sugawara Y; Hayashi M; Abe F; Takeuchi T
    J Antibiot (Tokyo); 1990 Dec; 43(12):1590-6. PubMed ID: 2276976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of autoimmune diseases.
    Marques A; Müller S
    Curr Drug Discov Technol; 2009 Dec; 6(4):262-9. PubMed ID: 20025594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim report of clinical studies presented at the International Symposium on Ciclosporin in Auto-Immune Diseases, Basel, March 18-20, 1985.
    Schmitz-Schumann M
    Prog Allergy; 1986; 38():436-46. PubMed ID: 3755240
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
    Ikehara S; Shimamura K; Aoyama T; Fujii S; Hamashima Y
    Immunology; 1985 Aug; 55(4):595-600. PubMed ID: 4018844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.
    Schorlemmer HU; Bartlett RR; Schleyerbach R; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):471-84. PubMed ID: 1841036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxyspergualin--a different and intriguing immunosuppressant.
    Tufveson G; Gannedahl G
    Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
    [No Abstract]   [Full Text] [Related]  

  • 14. Type I interferon in organ-targeted autoimmune and inflammatory diseases.
    Crow MK
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S5. PubMed ID: 21303493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lymphocytic antibody and autoimmune disease: a review.
    Denman AM
    Clin Exp Immunol; 1969 Sep; 5(3):217-49. PubMed ID: 4980325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic autoimmune diseases].
    Kawai S; Takagi K; Kusunoki Y; Nishio S; Matsumoto N
    Nihon Rinsho; 2008 Jan; 66(1):130-6. PubMed ID: 18193552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lupus nephritis with azathioprine.
    Maher JF; Schreiner GE
    Arch Intern Med; 1970 Feb; 125(2):293-8. PubMed ID: 5412919
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of cyclosporine in the treatment of autoimmune disorders.
    Favre H; Miescher PA; Lemoine R
    Transplant Proc; 1994 Dec; 26(6):3194-6. PubMed ID: 7998112
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH will partner drug industry to study Alzheimer's, diabetes, and autoimmune disorders.
    McCarthy M
    BMJ; 2014 Feb; 348():g1397. PubMed ID: 24502929
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal models of autoimmune diseases.
    Burkhardt H; Kalden JR
    Rheumatol Int; 1997; 17(3):91-9. PubMed ID: 9352602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.